Search

Issue Volume 32(2022)Supplement 2

92. 2022-RA-1105-ESGO Can preoperative FDG-PET/CT help to predict complete resection at primary citorreductive surgery in highly pre-selected patients?. (20th October 2022)

Authors:
Boria, Felix; Zapardiel, Ignacio; Gutierrez, Monica; Carbonell, Maria; Sancho, Lidia; Chacón, Enrique; Manzour, Nabil; Hernandez, Alicia; Chiva, Luis
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A300
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

94. 2022-RA-1107-ESGO Hysterectomy after radical vaginal trachelectomy – is this a 'must' in early stage cervical cancer? Our 15 years clinical experience benchmarked with the current state of science. (20th October 2022)

Authors:
Cepraga, Irina; Auletta, Valentina; Bokhua, Davit; Kather, Angela; Runnebaum, Ingo B
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A43
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

95. 2022-RA-1110-ESGO Impact of comorbidities, postoperative complications and center volume on overall survival in a real-life cohort of 29, 879 ovarian cancer patients. (20th October 2022)

Authors:
Jochum, Floriane; Petit, Anne-Sophie Hamy; Laas, Enora; Daoud, Eric; Dumas, Elise; Kassara, Amyn; Gougis, Paul; Gaillard, Thomas; Lecointre, Lise; Akladios, Cherif; Lecuru, Fabrice; Reyal, Fabien
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A300
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

96. 2022-RA-1111-ESGO Case studies as a valuable tool to improve physician competence regarding identification of patients and selection of treatment for newly diagnosed advanced ovarian cancer. (20th October 2022)

Authors:
Johnson, Ben; Cannon, Megan; Vandenbroucque, Juliette; Parada, Yelena; Lucero, Katie
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A300
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

97. 2022-RA-1112-ESGO MFAP5 is related to ovarian cancer progression but not suitable as prognostic biomarker. (20th October 2022)

Authors:
Kujawa, Katarzyna Aleksandra; Zembala-Nożyńska, Ewa; Syrkis, Joanna; Cortez, Alexander Jorge; Kupryjańczyk, Jolanta; Lisowska, Katarzyna Marta
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A301
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

98. 2022-RA-1114-ESGO BRCA I, BRCA II mutation in high grade ovarian cancers, fallopian tube cancer, primary peritoneal carcinoma. (20th October 2022)

Authors:
Trukhan, Hanna; Skachkova, Valeria; Lufiarova, Yuliya Lufiarova; Mavrichev, Sergey; Dalamanava, Elena; Ramanovich, Volha
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A301
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

100. 2022-RA-1116-ESGO Barriers in the cervical cancer screening program and how self-sampling for HPV-testing is experienced as a solution to them. (20th October 2022)

Authors:
Payrich, Eva Maria; Skof, Anna Sophie; Struck, Maja; Thies, Sarah; Schreckenberger, Carola; Sehouli, Jalid; Kaufmann, Andreas Martin
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A380
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search